• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国基于人群的研究:胰头、体和尾部癌症的发病率和生存率。

Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States.

机构信息

Sections of Gastroenterology and Health Services Research, Department of Veterans Affairs Medical Center, Houston, TX, USA.

出版信息

Pancreas. 2010 May;39(4):458-62. doi: 10.1097/MPA.0b013e3181bd6489.

DOI:10.1097/MPA.0b013e3181bd6489
PMID:19924019
Abstract

OBJECTIVES

Cancer of the body/tail of the pancreas is frequently separated from pancreatic head tumors. No studies have examined whether the demographics, disease characteristics, and patient survival with pancreatic body/tail cancers are different from pancreatic head tumors.

METHODS

We used the Surveillance, Epidemiology, and End Results (SEER) registry to identify 43,946 cases of pancreatic cancer. The yearly incidence and survival rates were calculated. Cox proportional hazards model examined temporal trends in survival.

RESULTS

The incidence rate for pancreatic head cancer has remained at 5.6% per 100,000, whereas the rate for pancreatic body/tail cancers has increased by 46% between 1973 and 2002. The 3-year survival rate has increased slightly for both groups. The Cox proportional hazards model analysis confirms this improvement. The 3-year survival rate for local-stage pancreatic body/tail cancer is 20.0% compared with 9% for local-stage pancreatic head cancer.

CONCLUSIONS

This study indicates that the incidence of pancreatic head cancer has remained stable, whereas the incidence of pancreatic body/tail cancers is rising. Despite higher survival rates among patients with pancreatic head cancer compared with those with pancreatic body/tail cancers in several variables, patients with local-stage pancreatic body/tail cancers had higher survival rates compared with local-stage pancreatic head cancer.

摘要

目的

体尾部胰腺癌常常与胰头部肿瘤相分离。目前尚无研究探讨体尾部胰腺癌患者的人口统计学特征、疾病特征和生存情况是否与胰头部肿瘤不同。

方法

我们利用监测、流行病学和最终结果(SEER)登记处的数据,确定了 43946 例胰腺癌患者。计算了每年的发病率和生存率。Cox 比例风险模型用于检验生存时间趋势。

结果

胰头部癌症的发病率保持在每 100000 人 5.6%,而 1973 年至 2002 年期间体尾部癌症的发病率增加了 46%。两组的 3 年生存率均略有提高。Cox 比例风险模型分析证实了这一改善。局部期体尾部胰腺癌的 3 年生存率为 20.0%,而局部期胰头部癌症的 3 年生存率为 9%。

结论

本研究表明,胰头部癌症的发病率保持稳定,而体尾部癌症的发病率正在上升。尽管在多个变量中,胰头部癌症患者的生存率高于体尾部癌症患者,但局部期体尾部癌症患者的生存率高于局部期胰头部癌症患者。

相似文献

1
Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States.美国基于人群的研究:胰头、体和尾部癌症的发病率和生存率。
Pancreas. 2010 May;39(4):458-62. doi: 10.1097/MPA.0b013e3181bd6489.
2
The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.根治性手术对胰腺癌患者生存的影响:一项基于美国人群的研究。
Am J Gastroenterol. 2007 Jul;102(7):1377-82. doi: 10.1111/j.1572-0241.2007.01202.x. Epub 2007 Mar 31.
3
Anal canal cancer: a population-based reappraisal.肛管癌:基于人群的重新评估。
Dis Colon Rectum. 2003 Nov;46(11):1517-23; discussion 1523-4; author reply 1524. doi: 10.1097/01.DCR.0000093722.63657.B4.
4
Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.新辅助放疗与可切除胰腺癌患者的生存率提高相关:基于监测、流行病学和最终结果(SEER)登记处数据的分析
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128-33. doi: 10.1016/j.ijrobp.2008.02.065. Epub 2008 Jun 4.
5
Are survival rates different for young and older patients with rectal cancer?年轻和老年直肠癌患者的生存率有差异吗?
Dis Colon Rectum. 2004 Dec;47(12):2064-9. doi: 10.1007/s10350-004-0738-1.
6
Trends in the incidence and treatment of parathyroid cancer in the United States.美国甲状旁腺癌的发病率及治疗趋势。
Cancer. 2007 May 1;109(9):1736-41. doi: 10.1002/cncr.22599.
7
Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival.在美国,非贲门胃腺癌仍然是一种重要的致命癌症:发病率和生存率的长期趋势。
Am J Gastroenterol. 2006 Nov;101(11):2485-92. doi: 10.1111/j.1572-0241.2006.00778.x. Epub 2006 Oct 4.
8
The epidemiology of pancreatic cancer in the United States: changes below the surface.美国胰腺癌的流行病学:表象之下的变化
Aliment Pharmacol Ther. 2006 Jul 1;24(1):87-94. doi: 10.1111/j.1365-2036.2006.02961.x.
9
[Surgical effect of malignant tumor of body and tail of the pancreas: compare with pancreatic head cancer].[胰体尾恶性肿瘤的手术效果:与胰头癌比较]
Zhonghua Wai Ke Za Zhi. 2007 Jan 1;45(1):30-3.
10
Population-based study of islet cell carcinoma.基于人群的胰岛细胞癌研究。
Ann Surg Oncol. 2007 Dec;14(12):3492-500. doi: 10.1245/s10434-007-9566-6. Epub 2007 Sep 26.

引用本文的文献

1
Establishment of nomogram of early death in elderly pancreatic cancer patients with liver metastasis.老年胰腺癌肝转移患者早期死亡列线图的建立。
Discov Oncol. 2025 Mar 17;16(1):333. doi: 10.1007/s12672-025-02059-4.
2
Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data.转移性胰腺癌系统化疗的成本效益:一项使用日本临床数据的回顾性研究。
Sci Rep. 2025 Jan 2;15(1):267. doi: 10.1038/s41598-024-80549-1.
3
An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images.
利用计算机断层扫描图像洞察胰腺不同亚区域的胰腺癌肿瘤异质性。
Front Oncol. 2024 Nov 12;14:1378691. doi: 10.3389/fonc.2024.1378691. eCollection 2024.
4
Increased risk of multiple metastases and worse overall survival of metastatic pancreatic body and tail cancer: a retrospective cohort study.胰体尾癌发生多处转移的风险增加及转移性胰体尾癌总体生存率更差:一项回顾性队列研究
Gland Surg. 2024 Apr 29;13(4):480-489. doi: 10.21037/gs-23-465. Epub 2024 Apr 26.
5
Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery.多模态方法在胰腺癌手术患者选择中的应用。
Curr Oncol. 2024 Apr 15;31(4):2260-2273. doi: 10.3390/curroncol31040167.
6
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study.基于临床影像组学模型预测胰腺导管腺癌生存结局的研究:一项多中心回顾性研究
Diagnostics (Basel). 2024 Mar 28;14(7):712. doi: 10.3390/diagnostics14070712.
7
Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail.胰头与胰体尾导管腺癌的比较分子图谱分析
NPJ Precis Oncol. 2024 Apr 6;8(1):85. doi: 10.1038/s41698-024-00571-4.
8
Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.早期胰腺癌——利用真实世界数据探索当代治疗方法和结果。
Br J Cancer. 2024 May;130(9):1477-1484. doi: 10.1038/s41416-024-02619-5. Epub 2024 Mar 6.
9
Obesity Is Associated with Distal Migration of Pancreatic Adenocarcinoma to Body and Tail: A Multi-Center Study.肥胖与胰腺腺癌向体尾部的远端转移有关:一项多中心研究。
Cancers (Basel). 2024 Jan 14;16(2):359. doi: 10.3390/cancers16020359.
10
Splenic Hilar Involvement and Sinistral Portal Hypertension in Unresectable Pancreatic Tail Cancer.不可切除的胰尾癌中的脾门受累及左侧门静脉高压
Cancers (Basel). 2023 Dec 15;15(24):5862. doi: 10.3390/cancers15245862.